Skip to main content

Advertisement

Fig. 1 | Basic and Clinical Andrology

Fig. 1

From: Hormonal, chemical and thermal inhibition of spermatogenesis: contribution of French teams to international data with the aim of developing male contraception in France

Fig. 1

Effect of oral medroxyprogesterone (20 mg/day) and percutaneous testosterone (50–125 mg/day) treatment on sperm count. Number of subjects n = 30. Subjects with sperm counts > 1 million/ml at 3 months (n = 5) were considered as poor responders, while good responders were subjects with sperm counts < 1 million/ml at 1 month (rapid responders, n = 4), 2 months (intermediate responders, n = 11) and 3 months (slow responders, n = 10)

Back to article page